The Cancer Letter

Inside information on cancer research and drug development

Vol.
29
No.
46
December 12, 2003Dec 12, 2003
Free
DOWNLOAD THE PDF

NCI’s use of Cancer Dialogue for biospecimen network blueprint raises legal, procedural questions.

Plan posted for “public comment” on Dialogue’s Web site; who will respond, Dialogue or NCI? Cost estimate of network significantly reduced.

Also Stillman named director, Cold Spring Harbor, Watson is chancellor.

Pollin Prize honors four pioneers in treatment of childhood leukemia.

December Business & Regulatory Report included in this issue.

The Cancer Letter takes two-week break; next issue Jan. 2.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account